# Candel Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 18, 2026

- Company: [Candel Therapeutics, Inc.](/companies/cadl.md) (CIK 1841387)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-18
- Accepted by EDGAR: Mar 18, 2026, 16:23 ET
- Period: not reported
- Accession: 0001494695-26-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1841387/000149469526000005/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841387/000149469526000005/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841387/000149469526000005/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001494695-26-000005. Last ingested by Listed: Nov 5, 2026, 18:42 ET. No prices; not investment advice.